To improve anemia, due to the incapacity of the failing kidneys to produce EPO and to the low circulating iron available for hemoglobin synthesis in the erythropoietic process, dialysis patients need to be treated with ESA and iron. This evidence concerns the gene EPO and anemia (phenotype).